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Abstract : The purpose of this study was to examine the effects of a 6-month exercise program 
on submaximal walking economy in individuals with peripheral arterial disease and intermit-
tent claudication (PAD-IC). Participants (n = 16) were randomly allocated to either a control 
PAD-IC group (CPAD-IC, n = 6) which received standard medical therapy, or a treatment 
PAD-IC group (TPAD-IC; n = 10) which took part in a supervised exercise program. During a 
graded treadmill test, physiological responses, including oxygen consumption, were assessed to 
calculate walking economy during submaximal and maximal walking performance.   Differences 
between groups at baseline and post-intervention were analyzed via Kruskal–Wallis tests. 
At baseline, CPAD-IC and TPAD-IC groups demonstrated similar walking performance and 
physiological responses. Postintervention, TPAD-IC patients demonstrated significantly lower 
oxygen consumption during the graded exercise test, and greater maximal walking performance 
compared to CPAD-IC. These preliminary results indicate that 6 months of regular exercise 
improves both submaximal walking economy and maximal walking performance, without 
significant changes in maximal walking economy. Enhanced walking economy may contribute 
to physiological efficiency, which in turn may improve walking performance as demonstrated 
by PAD-IC patients following regular exercise programs.
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Introduction
Peripheral arterial disease (PAD) is a common circulatory problem arising from 
decreased blood flow, and is usually secondary to atherosclerosis in the arteries 
of the lower limbs. The most common presenting symptom of PAD is intermittent 
  claudication (IC), with exercise-induced pain experienced in the calves, thighs or 
  buttocks that is relieved with rest.1,2 Compared to healthy, age-matched controls, 
patients with PAD-IC demonstrate reduced physiological capacity, limited lower limb 
mobility (temporal-spatial parameters and joint angular kinematics), poor   walking 
performance (maximal walking distance/time), low physical activity levels, and 
decreased health-related quality of life.3–7
Over the past 4 decades, numerous studies have employed short- and long-term tread-
mill walking programs for PAD sufferers, resulting in significant improvement in both 
pain-free walking and maximal walking times.7–9 However, the mechanism(s) for such 
enhanced walking performance has yet to be determined. A variety of   possible   mechanisms 
have been suggested, including increased blood flow, improved   mitochondrial oxidative 
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capacity, greater skeletal muscle   diffusive   capacity, capillary 
growth, higher oxygen perfusion in the area of the arterial 
obstruction, advances in walking economy (ie, a decrease in 
whole-body oxygen uptake), and changes in lower limb gait 
characteristics.6,10–15   Determination of the mechanisms for 
improved walking performance will provide clinicians with 
valuable information for the prescription and management of 
treatment plans for PAD-IC patients.
In our previous research, we showed that while a 
12-month supervised exercise program improved the 
  walking performance of PAD-IC patients, the improve-
ment may not be due to changes in either lower limb 
temporal-spatial gait parameters, or angular kinematics.7 
Therefore, physiological mechanisms may be responsible 
for the improved walking performance demonstrated 
in our research,7 and the research of others.16–18 Studies 
have demonstrated that supervised exercise programs can 
improve the peak aerobic capacity (ie, peak oxygen uptake, 
[  VO2peak]) of PAD-IC-affected individuals by an average of 
1–3 mL ⋅ kg-1 ⋅ min-1 depending on the intensity and dura-
tion of the exercise sessions.10,12,19 Few studies have exam-
ined the possibility that exercise-induced improvements in 
pain-free and maximal walking time in this population may 
in fact be due to improved   walking economy as indicated 
by reduced submaximal   VO2. An increase in walking 
submaximal economy efficiency may reflect an improve-
ment in biomechanical and physiological components, 
thereby improving functional capacity. To our knowledge, 
there have been only a small number of studies to date 
which have examined submaximal walking economy in 
PAD patients. These studies demonstrated that walking 
economy, as measured by   VO2 during the final minute 
of steady-state submaximal walking, improved following 
a 6-month exercise rehabilitation program, and strength 
increases in PAD patients correlated to decreases in VO2 
measures.4,20 It should be noted that walking economy in 
these studies was assessed at a single time point: either 
the final or first minute of exercise prior to training, and 
then at the same time point following training, thereby 
ensuring the absolute workload was the same, and therefore 
  comparable.   However, the limitation of this might be the 
value of assessing economy during the first or final minute 
of a test, as the patients are likely to be relying heavily on 
anaerobic pathways and hyperventilating, which would sig-
nificantly impair the ability to rely on indirect calorimetry 
for the determination of energy expenditure.
Further and more detailed analysis of submaximal 
walking is required to clarify the role of walking economy 
as a mechanism for walking performance improvement, 
  following regular exercise. Alterations in submaximal 
  walking economy may explain why patients increase their 
walking performance without an increase in peripheral blood 
flow, following supervised exercise programs.12,21
The aim of this study was to examine the effects of a 
6-month supervised exercise program on both submaximal 
walking economy and walking performance in   individuals 
with PAD-IC. It was hypothesized that the supervised 
  exercise program would result in an improvement in both 
walking performance and submaximal walking economy 
during a graded walking treadmill test, compared to baseline 
and control PAD-IC participants.
Materials and methods
Participants
Patients referred to the Vascular Department at the 
  Townsville Hospital (Queensland, Australia) with   symptoms 
of IC were considered for inclusion in this study, as part 
of a larger study.6,7 Entry criteria included an   appropriate 
history of IC, imaging confirmation of PAD on lower limb 
duplex or computed tomographic angiography (CTA), and 
ability and willingness to attend for regular supervised 
exercise. Exclusion criteria included selection for surgical 
or endovascular intervention (n = 30), patient preference 
(n = 20) and requirement for mobility aids, obvious gait 
abnormalities (eg, steppage, vaulting, circumduction and 
hip hiking), or medical conditions which influenced gait 
(eg, orthopedic conditions and neurological impairment). 
Clinical data, including atherosclerotic risk factors and 
medication history were collected during consultations with 
a vascular   physician. Diabetes, hypertension, arthritis and 
ischemic heart disease were defined by history of diagnosis 
or previous treatment of these conditions. PAD-IC was 
confirmed by the absence of peripheral pulses, lower limb 
artery stenosis or occlusion on duplex or CTA, and ankle-
brachial pressure index ,0.9.22
Participants were randomly allocated using a blinded 
protocol to either a control (CPAD-IC, n = 11) or   treatment 
(TPAD-IC, n = 11) group. Patients randomized to the 
TPAD-IC experimental condition undertook a 6-month 
supervised exercise program, while CPAD-IC patients 
continued with standard medical treatment as outlined in 
the Trans-Atlantic Inter-Society Consensus (TASC II) 
guidelines.23–25 All participants volunteered and gave written 
informed consent to participate in this study, with all proce-
dures undertaken in accordance with the principles outlined 
in the Declaration of Helsinki. Approval for the study was 
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obtained from both the local university and health district 
research ethics committees.
Procedure
Participants arrived at the laboratory in the early morning 
during a 12-hour fasting state, and underwent an assessment 
of body composition, resting ankle/brachial pressure index 
and a graded treadmill exercise test. The same procedures 
were completed prior to (0-month) and following the inter-
vention (6-month) period.
Body composition
Participant height was determined by a wall mounted 
stadiometer (model 220, Seca Scales, Hamburg, Germany). 
Body mass and composition (% body fat) were determined 
via bioelectrical impedance scales (TANITA TBF 521, 
TANITA Corporation, Arlington Heights, Il).
Ankle/brachial index
Blood pressure measurements were taken by a qualified 
sonographer using a handheld bidirectional Doppler instru-
ment (MD6, Hokanson, Bellevue, WA) with a 5-MHz trans-
ducer and standard blood pressure cuffs after the participant 
had rested in the supine position for 15 minutes. Ankle/
brachial index (ABI) was calculated as the highest systolic 
blood pressure in the posterior tibial artery or dorsalis pedis 
artery, divided by the highest systolic blood pressure in the 
left or right brachial artery.26
Graded treadmill exercise test
Participants then underwent a graded exercise test on 
a treadmill (Trackmaster TMX55, Full Vision, KS). 
The   physiological responses assessed including   VO2, 
  respiratory exchange ratio (RER) and ventilation (  VE), were 
  determined via indirect calorimetry using a metabolic cart 
(POWERLAB/8M Metabolic System, ADInstruments Pty 
Ltd, Castle Hill, Australia). Heart rate (HR) was recorded 
using a bioamp as previously described.7 All physiological 
responses were recorded continuously using Chart (v5.1, 
ADInstruments Pty Ltd) sampling at 1000 Hz, and were 
later analyzed as 15-second averages. Walking economy 
was assessed by  VO2 at 15-second periods during the graded 
treadmill test and compared against values predicted using the 
American College of Sports Medicine (ACSM) equations for 
a typical healthy population.27 Similar calculations have been 
utilized previously for walking economy in PAD patients.4
The graded treadmill walking protocol consisted of a 
constant speed of 3.2 km ⋅ h -1 (0.88 m ⋅ s -1) at an incline of 0% 
for the first 2 minutes, which was then increased by 2% every 
2 minutes.28 Participant perception of exercise exertion was 
determined every 60 seconds via Borg’s Rating of Perceived 
Exertion (RPE) instrument,29 while participant perception of 
claudication pain was determined via a 5-point scale, (0 = no 
pain, 1 = onset of pain, 2 = moderate pain, 3 = intense pain, 
4 = maximal pain) the Claudication Pain Scale (CPS).27 
Walking performance was assessed as pain-free walking 
time (PFWT) and maximal walk time (MWT) determined 
via perceived maximal pain or volitional exhaustion.
Supervised exercise program
As previously described,7 the exercise program initially 
  consisted of intermittent supervised treadmill walking 
3 days per week for a total time of 25 minutes at 3.2 km ⋅ hr-1 
(0.88 m ⋅ s-1). Participants were required to walk until the pain 
level was perceived as being 3 or 4 on the CPS.   Exercise 
intensity (via treadmill grade and walking speed) and duration 
(25 minutes up to a maximum of 40 minutes) were progres-
sively increased once the participant could walk continuously 
for 25 minutes at a level below 3 on the CPS pain scale. This 
exercise progression strategy was continued over the 6-month 
period of the study.
Statistical analyses
Statistical analyses were performed using the SPSS software 
program (v16.0, SPSS Inc, Chicago, Il). Descriptive statistics 
were expressed as mean (± SD). Box-plot analyses were per-
formed to identify extreme and outlier data. Medication and 
comorbidities data were analyzed using the nonparametric 
Friedman test, and post hoc comparison using Nemenyi’s 
test. Due to the restricted sample size, multiple Kruskal–
Wallis tests were performed for CPAD-IC versus TPAD-IC 
at 0 months and CPAD-IC versus TPAD-IC at 6 months. 
An alpha level of 0.05 was adopted for this study.30 Due to 
the limited walking ability of some participants (perceived 
maximal pain or volitional exhaustion within 3 minutes), 
walking economy was only assessed for the first 3 minutes 
of the graded treadmill test, in order to provide maximal 
comparison between groups. The TPAD-IC group attended 
80% of the training sessions during the 6-month period of 
the study.
Results
Participants
The participant groups were similar in age, height, mass 
and % body fat at baseline (P . 0.05). For personal   reasons, 
six participants (n = 5 CPAD-IC and n = 1 TPAD-IC) 
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  withdrew over the course of the research study. Baseline data 
for the two groups were similar after excluding the patients 
that dropped out (Table 1). Both groups had bilateral PAD, as 
indicated by ABI, with similar severity between groups. The 
groups were similar with respect to risk factors, comorbidities 
and medications; however, the CPAD-IC group consisted 
of a higher proportion of patients who had been diagnosed 
with hypertension (P , 0.05), compared to the TPAD-IC 
group (Table 1).
Treadmill testing
The groups had similar PFWT and MWT at baseline. 
  Following the 6-month supervised exercise program, TPAD-
IC participants demonstrated significantly greater PFWT and 
MWT compared to the CPAD-IC group (Table 2). All peak 
physiological responses (HR,  VO2,  VE and RER) were simi-
lar between groups at baseline, and following the 6-month 
intervention (Figures 1 and 2).
Walking economy was similar at baseline in both groups, 
and was greater than that for a healthy population based on 
the ACSM equations (Figure 1A). Following the 6-month 
supervised exercise program, the TPAD-IC demonstrated 
significantly-reduced  VO2 during the graded treadmill test at 
the 60, 75, and 180 second intervals, and had values closer to 
those for a healthy population based on the ACSM equations 
(Figure 1B). During the graded treadmill walk, TPAD-IC 
displayed significantly-reduced RER values from 90 seconds 
until 180 seconds, compared to CPAD-IC postintervention 
(Figure 2D). A correlation analysis found a low-to-moderate 
result between walking economy and MWT for both 0 and 
6 months.
Discussion
The purpose of this study was to investigate the effects of 
a 6-month supervised exercise program on submaximal 
walking economy and walking performance of individuals 
with PAD-IC. The results of this study impact upon those of 
others,4,31 by demonstrating some significant improvements 
in submaximal walking economy during the testing proto-
col following regular exercise. The submaximal walking 
economy values from the current study were similar to 
those reported by Gardner et al,4 with the TPAD-IC group 
improving their PFWT and MWT by 245% and 128% 
respectively, said values being greater than those previously   
exhibited by PAD patients.4
The current results indicate that enhanced submaximal 
walking economy contributes to improved walking per-
formance for PAD-IC patients following regular exercise. 
Furthermore, the improved walking economy of TPAD-IC 
patients appears to approach values predicted by the ACSM 
equations for healthy adults. This trend suggests that regular 
exercise enhances submaximal walking economy towards 
healthy values which may in turn contribute to greater 
independence for PAD-IC patients.10
While greater submaximal walking economy was demon-
strated by TPAD-IC, the mechanism(s) for such improvement 
Table 1 Descriptive characteristics of participants
Variable CPAD-IC  
(n = 6)
TPAD-IC  
(n = 10)
0 month 6 months  0 month 6 months
Age (y) 67.1 (±6.8) 68.1 (±6.8) 71.3 (±8.5) 72.3 (±8.5)
Height (cm) 167.7 (±3.0) 168.0 (±3.2) 165.7 (±2.4)  165.7 (±2.5)
Mass (kg) 72.4 (±6.0) 72.8 (±6.0) 80.7 (±4.6) 79.4 (±4.6)
Body fat (%) 29.2 (±3.6) 30.5 (±2.6) 33.1 (±2.8) 34.5 (±2.0)
BMI (kg ⋅ m -2) 25.7 (±4.9) 25.8 (±5.4) 29.2 (±4.1) 28.8 (±3.9)
ABI left leg 0.53 (±0.08) 0.53 (±0.08) 0.72 (±0.06) 0.70 (±0.06)
ABI right leg 0.66 (±0.11) 0.69 (±0.11) 0.71 (±0.09) 0.74 (±0.09)
Gender (% male) 50% 50%
Current smoker (%) 30% 10%
Former smoker (%) 75% 77%
Type II diabetes (%) 17% 10%
Hypertension (%) 50% 10%*
Ischemic heart disease (%) 33% 20%
Arthritis (%) 0% 10%
Beta-blocker prescription (%) 33% 10%
Notes: Values are mean (± SD) or %. *P , 0.01 versus CPAD-IC.
Abbreviations: ABI, Ankle/brachial index; BMI, Body Mass Index; CPAD-IC, control peripheral arterial disease-intermittent claudication patients; TPAD-IC, treatment 
peripheral arterial disease-intermittent claudication patients.
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Figure 1 Walking economy during graded treadmill testing at 0- and 6-months for control peripheral arterial disease-intermittent claudication patients (CPAD-IC) and 
treatment for peripheral arterial disease-intermittent claudication patients (TPAD-IC).
Note: *P , 0.05 versus TPAD-IC.
Table 2 Pain free walking time and maximal walking time prior to 
and following 6 month supervised exercise training
0 month 6 months
CPAD-IC  
(n = 10)
TPAD-IC  
(n = 6)
CPAD-IC 
(n = 10)
TPAD-IC 
(n = 6)
PFWT (s) 115.7  
(±97.9)
134.8  
(±54.1)
139.8  
(±79.7)
465.5  
(±325.1)*
MWT (s) 288.2 
(±100.8)
335.5 
(±140.2)
360.7  
(±131.9)
766.9  
(±317.9)*
Notes: Values are mean (± SD). *P , 0.05 versus 6-month CPAD-IC.
Abbreviations:  CPAD-IC,  control  peripheral  arterial  disease-intermittent 
claudication patients; MWT, maximal walking time; PFWT, pain free walking time; 
TPAD-IC, treatment peripheral arterial disease-intermittent claudication patients.
remains unknown. Prior studies have reported an increase in 
peripheral limb blood for PAD-IC patients at rest   following 
an exercise program;4,15 however, increased blood flow during 
exercise remains controversial due to sound methodology to 
measure blood flow during exercise.12,19 Increased limb blood 
flow may result in increased oxygen supply/perfusion, reduced 
submaximal   VO2, improved walking economy and reduced 
claudication pain. The current study demonstrated that sub-
maximal  VO2 was reduced after an exercise training program, 
and may provide an indirect indicator of improved peripheral 
limb blood flow during exercise for TPAD-IC patients. Train-
ing-induced increases in oxygen saturation of the calf muscle 
during treadmill walking provides further support for improved 
lower-limb oxygen delivery for PAD patients.32
While improved blood flow has been proposed, the 
consistent lack of training-induced increases of resting and 
postexercise blood flow,15 and minimal changes in angiogenic 
factors,33 imply that other mechanisms may contribute to the 
greater walking performance for PAD patients, post-training. 
For example, Figoni et al34 reported lower oxygen saturation 
levels (greater calf deoxygenation) during exercise for PAD 
participants following regular exercise. The lower saturation 
values represented increased tissue perfusion and enhanced 
oxygen extraction as a result of regular exercise training.34 
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Similar results of greater oxygen extraction during exercise 
have been seen in animals, with signs of IC following high 
intensity training.35 These authors reported greater mito-
chondrial content post-training as a contributing factor for 
the training-induced improved performance.35 Others have 
proposed similar improvements in localized muscle metabo-
lism for the training-induced improvements in muscular 
activity.36,37 Most notably, carnitine, an important cofactor 
involved in lipid metabolism, has been augmented following 
training in PAD patients.36,37
Subsequently, regular training may result in greater 
carnitine and lipid metabolism for PAD-IC patients. During 
the submaximal walking test, TPAD-IC patients exhibited 
significantly-reduced RER values, which are indicative of 
an increased lipid metabolism. Enhanced lipid use reflects 
an important training-induced adaptation following regular 
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Figure 2 Submaximal and peak physiological characteristics during graded treadmill testing at 0- and 6-months for control peripheral arterial disease-intermittent claudication 
patients (CPAD-IC) and treatment for peripheral arterial disease-intermittent claudication patients (TPAD-IC).
Note: *P , 0.05 versus TPAD-IC.
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exercise,38,39 and, more importantly, may provide a key factor 
for the treatment of PAD. Given the significant relationship 
between obesity and PAD severity, and the risk of outcome 
events,40 the current results of greater lipid metabolism during 
submaximal walking provide further evidence of the benefits 
of regular exercise for the treatment of PAD-IC patients.
At present, the exact mechanisms for greater walking 
performance and lower submaximal walking economy in 
PAD-IC patients following regular exercise training are 
yet to be clarified. Examination of such variable factors as 
oxygen and blood flow kinetics during exercise, muscle 
metabolism, and mitochondrial content, will further clarify 
the role of these factors for improved walking performance 
and economy in PAD-IC patients.
Limitations
The main limitation of the current study was the small 
sample size, particularly the number of patients followed 
up at 6 months. While studies with greater patient numbers 
may provide further evidence for the impact of PAD on 
submaximal walking economy, comparable results between 
the current and prior study (maximal walking economy 
only)3 provide support for the significant influence of regular   
exercise on submaximal walking economy for PAD patients.
Additionally, although the CPAD-IC group was not 
  followed up with respect to other lifestyle factors during the 
6 months, the intent of this research study was to examine 
the differences between a supervised exercises group and 
a standard medical treatment group. Research may wish to 
place more control on participants’ medical treatment and 
general lifestyle in the future.
Conclusion
In conclusion, the results of this study demonstrated that a 
6-month supervised exercise program resulted in improved 
walking economy and greater fat metabolism during submax-
imal walking, and maximal walking performance for PAD-IC 
patients without significant alterations in peak physiological 
characteristics. The improved maximal walking performance 
for patients following regular exercise may be associated with 
improvements in submaximal walking economy, with further 
research to clarify the respective contributions of peripheral 
blood flow, muscle fiber and mitochondrial density to   
walking economy in PAD patients.
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